Related content

Imidazoline receptors: new targets for antihyperglycaemic drugs

By Morgan N.G.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 5, 1999-05 ,pp. : 575-584

Informa Healthcare

Access to resources Recommend Favorite

Imidazoline Binding Sites and Receptors in Cardiovascular Tissue - an investigation into their relationship to imidazoline, 2 and H 3 receptors

By Molderings G.J.   Gothert M.  

General Pharmacology, Vol. 32, Iss. 1, 1999-01 ,pp. : 17-22

Elsevier

Access to resources Recommend Favorite

I Imidazoline Agonists. General Clinical Pharmacology of Imidazoline Receptors: Implications for the Treatment of the Elderly

By Prichard B.N.   Graham B.R.  

Drugs & Aging, Vol. 17, Iss. 2, 2000-08 ,pp. : 133-159

Adis International

Access to resources Recommend Favorite

Evidence that the ability of imidazoline compounds to stimulate insulin secretion is not due to interaction with receptors

By Chan S.L.F.   Pallett A.L.   Clews J.   Ramsden C.A.   Morgan N.G.  

European Journal of Pharmacology, Vol. 323, Iss. 2, 1997-04 ,pp. : 241-244

Elsevier

Access to resources Recommend Favorite

Blockade by agmatine of catecholamine release from chromaffin cells is unrelated to imidazoline receptors

By Santos W.C.   Hernandez-Guijo J.M.   Ruiz-Nuno A.   Olivares R.   Jurkiewicz A.   Ganda L.   Garca A.G.  

European Journal of Pharmacology, Vol. 417, Iss. 1, 2001-04 ,pp. : 99-109

Elsevier

Access to resources Recommend Favorite